Rupa Srivastava, MD
Pediatrics · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Srivastava’s office at (408) 885-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A49761 · Current
Licensed to practise in California · since 1991 · expires 2027-07-31 · University of Delhi, Lady Hardinge Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$322,979 in 2024
Medicaid paid $322,979 for 4,483 billed services this clinician did in 2024, up to 179 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,266 | $317,266 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 177 | $2,368 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 329 | $1,648 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 158 | $650 |
| Short return visit (20+ min) | 362 | $262 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenACWY-TT), for intramuscular use | 26 | $240 |
| Short return visit | 696 | $220 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 60 | $100 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 170 | $93 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 380 | $50 |
| Measurement of bilirubin | 57 | $43 |
| Screening test, pure tone, air only | 313 | $38 |
| 2024 | 4,483 | 21 | 179 | $322,979 |
| 2023 | 3,701 | 17 | 135 | $291,932 |
| 2022 | 3,357 | 14 | 142 | $235,070 |
| 2021 | 3,565 | 14 | 121 | $289,858 |
| 2020 | 3,951 | 13 | 141 | $342,318 |
| 2019 | 3,368 | 17 | 135 | $247,374 |
| 2018 | 3,452 | 11 | 131 | $308,385 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,201 | $288,742 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 288 | $1,974 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 88 | $434 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 27 | $286 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 118 | $170 |
| Short return visit | 737 | $146 |
| Screening test, pure tone, air only | 419 | $90 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 28 | $50 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 313 | $30 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 14 | $10 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Bilateral quantitative screening test of visual acuity | 217 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,000 | $233,023 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 220 | $1,257 |
| Bilateral quantitative screening test of visual acuity | 271 | $145 |
| Short return visit | 694 | $144 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 53 | $137 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 53 | $80 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 91 | $80 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 43 | $50 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 19 | $50 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 164 | $47 |
| Screening test, pure tone, air only | 438 | $26 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 28 | $20 |
2021
| Clinic visit/encounter, all-inclusive | 1,242 | $287,472 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 147 | $954 |
| Short return visit | 876 | $792 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 124 | $140 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 84 | $110 |
| Bilateral quantitative screening test of visual acuity | 209 | $105 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 53 | $80 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 56 | $70 |
| Screening test, pure tone, air only | 284 | $70 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 151 | $55 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 83 | $10 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 172 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,483 | $338,769 |
| Short return visit (20+ min) | 669 | $1,027 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 206 | $867 |
| Short return visit | 554 | $791 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 433 | $260 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 133 | $160 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 131 | $160 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 107 | $120 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 37 | $93 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 74 | $70 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 12 | $0 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 88 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,060 | $241,328 |
| Short return visit | 466 | $1,406 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 171 | $1,172 |
| Short return visit (20+ min) | 233 | $857 |
| Screening test, pure tone, air only | 291 | $589 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 73 | $582 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 283 | $493 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 99 | $490 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 69 | $173 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use | 31 | $100 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 333 | $52 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 59 | $40 |
2018
| Clinic visit/encounter, all-inclusive | 1,280 | $261,981 |
| Short return visit | 505 | $11,175 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 202 | $9,564 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 373 | $6,578 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 137 | $6,110 |
| Short return visit (20+ min) | 209 | $5,865 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 579 | $3,248 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 47 | $2,960 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 14 | $585 |
| Screening test, pure tone, air only | 57 | $320 |
| Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv | 49 | $0 |
Professional record
- NPI
- 1033279716
- Licence
- CA A49761California A49761: Current · expires 2027-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-12-11
- NPI last updated
- 2013-05-07
This is when the NPI record was last certified, not a medical board exam.